ProfhEX: AI-based platform for small molecules liability profiling

[1]  E. Muratov,et al.  MolPredictX: Online Biological Activity Predictions by Machine Learning Models , 2022, Molecular informatics.

[2]  Daniel M. Wilson,et al.  Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches. , 2022, Computational toxicology.

[3]  Christopher M. Grulke,et al.  The effect of noise on the predictive limit of QSAR models , 2021, Journal of Cheminformatics.

[4]  M. Salem,et al.  MolData, a molecular benchmark for disease and target based machine learning , 2021, Journal of Cheminformatics.

[5]  Daniel P. Russo,et al.  In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities. , 2021, Computational toxicology.

[6]  F. Cedrón,et al.  A review on machine learning approaches and trends in drug discovery , 2021, Computational and structural biotechnology journal.

[7]  K. Héberger,et al.  Machine learning models for classification tasks related to drug safety , 2021, Molecular Diversity.

[8]  Pravir Kumar,et al.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery , 2021, Molecular Diversity.

[9]  A. Beccari,et al.  “Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool , 2021, Journal of Cheminformatics.

[10]  Sezen Vatansever,et al.  Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions , 2020, Medicinal research reviews.

[11]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[12]  Benjamin A. Shoemaker,et al.  PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..

[13]  Chaoyang Zhang,et al.  Structure–activity relationship-based chemical classification of highly imbalanced Tox21 datasets , 2020, Journal of Cheminformatics.

[14]  Prachi Pradeep,et al.  Variability in in vivo studies: Defining the upper limit of performance for predictions of systemic effect levels. , 2020, Computational toxicology.

[15]  Linlin Zhao,et al.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. , 2020, Drug discovery today.

[16]  Daniel Svozil,et al.  QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction , 2020, Journal of Cheminformatics.

[17]  D. Mendrick,et al.  An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). , 2020, Regulatory toxicology and pharmacology : RTP.

[18]  David Schaller,et al.  Next generation 3D pharmacophore modeling , 2020, WIREs Computational Molecular Science.

[19]  Ruili Huang,et al.  CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity , 2020, Environmental health perspectives.

[20]  Terry R Van Vleet,et al.  An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation. , 2020, Chemical research in toxicology.

[21]  Leela Sarath Kumar Konda,et al.  hERG liability classification models using machine learning techniques , 2019, Computational Toxicology.

[22]  Fredrik Svensson,et al.  LightGBM: An Effective and Scalable Algorithm for Prediction of Chemical Toxicity-Application to the Tox21 and Mutagenicity Data Sets , 2019, J. Chem. Inf. Model..

[23]  Xin Huang,et al.  Novel Computational Approach to Predict Off-Target Interactions for Small Molecules , 2019, Front. Big Data.

[24]  Andreas Bender,et al.  Leveraging heterogeneous data from GHS toxicity annotations, molecular and protein target descriptors and Tox21 assay readouts to predict and rationalise acute toxicity , 2019, Journal of Cheminformatics.

[25]  Friedrich Rippmann,et al.  Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting , 2019, Journal of Cheminformatics.

[26]  Andrew R. Leach,et al.  Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery , 2019, Journal of Cheminformatics.

[27]  Andrew R. Leach,et al.  ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..

[28]  Jean-Louis Reymond,et al.  Polypharmacology Browser PPB2: Target Prediction Combining Nearest Neighbors with Machine Learning , 2018, J. Chem. Inf. Model..

[29]  Ewgenij Proschak,et al.  Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds. , 2018, Journal of medicinal chemistry.

[30]  Hugo Ceulemans,et al.  Large-scale comparison of machine learning methods for drug target prediction on ChEMBL† †Electronic supplementary information (ESI) available: Overview, Data Collection and Clustering, Methods, Results, Appendix. See DOI: 10.1039/c8sc00148k , 2018, Chemical science.

[31]  Dongsup Kim,et al.  Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server , 2017, BMC Bioinformatics.

[32]  Minho Lee,et al.  Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server , 2017, BMC Bioinformatics.

[33]  R. Judson,et al.  Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates , 2017, Archives of Toxicology.

[34]  E. Blomme,et al.  Potential functional and pathological side effects related to off-target pharmacological activity. , 2017, Journal of pharmacological and toxicological methods.

[35]  George Papadatos,et al.  Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.

[36]  R. Vickery,et al.  Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists. , 2017, Bioorganic & medicinal chemistry letters.

[37]  Shuxing Zhang,et al.  Polypharmacology in Drug Development: A Minireview of Current Technologies , 2016, ChemMedChem.

[38]  Jie Dong,et al.  TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models , 2016, Journal of Computer-Aided Molecular Design.

[39]  Ruili Huang,et al.  CERAPP: Collaborative Estrogen Receptor Activity Prediction Project , 2016, Environmental health perspectives.

[40]  Robert Preissner,et al.  WITHDRAWN—a resource for withdrawn and discontinued drugs , 2015, Nucleic Acids Res..

[41]  Andreas Bender,et al.  Target prediction utilising negative bioactivity data covering large chemical space , 2015, Journal of Cheminformatics.

[42]  Luca Pinzi,et al.  Computational polypharmacology comes of age , 2015, Front. Pharmacol..

[43]  V. Setola,et al.  Further evaluation of the tropane analogs of haloperidol. , 2014, Bioorganic & medicinal chemistry letters.

[44]  J. Bajorath,et al.  Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.

[45]  Jean-Louis Reymond,et al.  Expanding the fragrance chemical space for virtual screening , 2014, Journal of Cheminformatics.

[46]  M. Pangalos,et al.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.

[47]  P. M. Thompson,et al.  Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. , 2014, Bioorganic & Medicinal Chemistry Letters.

[48]  Andreas Bender,et al.  In Silico Target Predictions: Defining a Benchmarking Data Set and Comparison of Performance of the Multiclass Naïve Bayes and Parzen-Rosenblatt Window , 2013, J. Chem. Inf. Model..

[49]  Lirong Wang,et al.  TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database , 2013, The AAPS Journal.

[50]  Gareth J Waldron,et al.  Reducing safety-related drug attrition: the use of in vitro pharmacological profiling , 2012, Nature Reviews Drug Discovery.

[51]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[52]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[53]  Roberto Todeschini,et al.  Comparison of Different Approaches to Define the Applicability Domain of QSAR Models , 2012, Molecules.

[54]  Pekka Tiikkainen,et al.  Computational tools for polypharmacology and repurposing. , 2011, Future medicinal chemistry.

[55]  Rainer E. Martin,et al.  Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonists. , 2010, Bioorganic & medicinal chemistry letters.

[56]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[57]  Sheng-Yong Yang,et al.  Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.

[58]  Thorsten Meinl,et al.  KNIME - the Konstanz information miner: version 2.0 and beyond , 2009, SKDD.

[59]  J. Goodier.  The Concise Encyclopedia of Statistics , 2009 .

[60]  Paolo Mazzatorta,et al.  Modeling Oral Rat Chronic Toxicity , 2008, J. Chem. Inf. Model..

[61]  Jean-Louis Reymond,et al.  Virtual Exploration of the Chemical Universe up to 11 Atoms of C, N, O, F: Assembly of 26.4 Million Structures (110.9 Million Stereoisomers) and Analysis for New Ring Systems, Stereochemistry, Physicochemical Properties, Compound Classes, and Drug Discovery , 2007, J. Chem. Inf. Model..

[62]  M. Ivanovic,et al.  Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor. , 2006, Bioorganic & medicinal chemistry.

[63]  Paola Gramatica,et al.  The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .

[64]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[65]  J. Friedman.  Greedy function approximation: A gradient boosting machine. , 2001 .

[66]  Dan Boneh,et al.  On genetic algorithms , 1995, COLT '95.

[67]  James E. Campbell,et al.  An Approach to Sensitivity Analysis of Computer Models: Part I—Introduction, Input Variable Selection and Preliminary Variable Assessment , 1981 .

[68]  Anton Simeonov,et al.  The US Federal Tox21 Program: A strategic and operational plan for continued leadership. , 2018, ALTEX.

[69]  Derek S. Tan,et al.  Principal component analysis as a tool for library design: a case study investigating natural products, brand-name drugs, natural product-like libraries, and drug-like libraries. , 2015, Methods in molecular biology.

[70]  Paola Gramatica,et al.  On the development and validation of QSAR models. , 2013, Methods in molecular biology.

[71]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[73]  V. Claassen.  Neglected factors in pharmacology and neuroscience research , 1994 .